catalog number :
MBS190567
products full name :
Anti-Inositol hexakisphosphate kinase 2 (IP6K2) Monoclonal Antibody
products short name :
IP6K2
products gene name :
IP6K2
specificity :
IP6K2. This antibody recognizes human IP6K2.
form :
100ug in PBS, pH 7.4, purified by Protein G affinity chromatography
storage stability :
This antibody is stable for at least one (1) year at -20 degree C. Avoid repeated freezing and thawing.
tested application :
Immunoblot
app notes :
Immunoblotting: A band of ~49 kDa is detected. User should determine optimal concentrations for their application. Positive control: purified human IP6K2 or NIH-OVCAR-3 cells after treatment with interferon (IFN)-beta.
other info1 :
Antigen: Full-length recombinant human IP6K2. Preservative: None
other info2 :
Dilution Instructions: Dilute in PBS or medium which is identical to that used in the assay system.
products description :
Inositol hexakisphosphate kinase 2 (IP6K2) catalyzes the production of diphosphoinositol pentakisphosphate (IP7) and has a role as a proapoptotic gene sensitizing cancer cells to apoptosis by cell stressors and anticancer drugs all of which depend on IP6K2 catalytic activity. IP6K2 is located in the 3p21.31 chromosomal region, which often undergoes allele loss in a variety of human cancers. Some heat shock proteins, especially Hsp90, can be antiapoptotic and the targets of anticancer drugs. Hsp90 binds IP6K2 and inhibits its catalytic activity. Drugs and selective mutations that abolish HSP90-IP6K2 binding elicit activation of IP6K2, leading to cell death. Thus, the prosurvival actions of HSP90 reflect the inhibition of IP6K2, suggesting that selectively blocking this interaction could provide effective and safer modes of chemotherapy.
products references :
Morrison, BH et al. 2002 Oncogene 21:1882-1889.